MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

164.68
+4.42
+2.76%
After Hours: 164.68 0 0.00% 16:59 05/14 EDT
OPEN
161.00
PREV CLOSE
160.26
HIGH
166.73
LOW
159.75
VOLUME
157.96K
TURNOVER
--
52 WEEK HIGH
196.12
52 WEEK LOW
78.46
MARKET CAP
5.92B
P/E (TTM)
38.97
1D
5D
1M
3M
1Y
5Y
Global Pharmacovigilance Outsourcing Market 2021, Segment by Types, Share, Growth, Application and Forecast to 2027 | Key Vendors are-Bioclinica, Parexel, MarksMan Healthcare, Oracle Corporation
May 06, 2021 (The Expresswire) -- The report on the Pharmacovigilance Outsourcing market provides a market analysis complete with a quantitative and...
The Express Wire · 05/06 18:09
Contract Research Organizations (CRO) Market (Based on 2020 COVID-19 Worldwide Spread) 2021 Industry Analysis, Trends, and Forecast 2027
May 06, 2021 (Heraldkeepers) -- Meticulous Research(R)- leading global market research company, published a research report titled "CROs Market by Services...
Heraldkeepers · 05/06 14:20
Cramer Advises Viewers On Fastly, Wells Fargo And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he expects more downgrades for Fastly Inc (NYSE: FSLY) on Thursday. He can't recommend the stock.
Benzinga · 05/06 12:34
Global Contract Research Organization (CRO) Market Report Analysis 2021-2026: Top Keyplayers Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL, ICON, Wuxi Apptec, Medpace Holdings etc
May 06, 2021 (The Expresswire) -- The research report based on Global Contract Research Organization (CRO) industry holds records related to important...
The Express Wire · 05/06 11:37
Clinical Trial Management System (CTMS) Market Share, Size, Growth, Business Demand, Global Market Analysis, Trends, Research and Forecast to 2026
May 06, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry.” Global “Clinical Trial Management System...
The Express Wire · 05/06 08:12
Shaker Investments Llc Buys MKS Instruments Inc, Snap-on Inc, Medpace Holdings Inc, Sells ...
GuruFocus News · 05/06 00:38
Cramer's lightning round: Buy more Wells Fargo
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 05/05 23:30
Medpace Holdings Stock Shows Every Sign Of Being Significantly Overvalued
GuruFocus News · 05/05 17:12
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MEDP. Analyze the recent business situations of Medpace Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MEDP stock price target is 180.25 with a high estimate of 200.00 and a low estimate of 160.00.
EPS
Institutional Holdings
Institutions: 415
Institutional Holdings: 29.21M
% Owned: 81.21%
Shares Outstanding: 35.97M
TypeInstitutionsShares
Increased
76
1.04M
New
25
542.28K
Decreased
96
1.02M
Sold Out
33
940.65K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.85%
Pharmaceuticals & Medical Research
+1.12%
Key Executives
Chairman/President/Chief Executive Officer/Director
August Troendle
Chief Financial Officer
Jesse Geiger
Executive Vice President
Susan Burwig
General Counsel/Secretary
Stephen Ewald
Lead Director/Independent Director
Fred Davenport
Independent Director
Brian Carley
Independent Director
Ashley Keating
Independent Director
Thomas King
Independent Director
Robert Kraft
Independent Director
Cornelius McCarthy
No Data
  • All
  • Financials
  • Insiders
More
About MEDP
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers kinds of Medpace Holdings Inc stock information, including NASDAQ:MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.